ATE495439T1 - Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren - Google Patents

Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren

Info

Publication number
ATE495439T1
ATE495439T1 AT05785092T AT05785092T ATE495439T1 AT E495439 T1 ATE495439 T1 AT E495439T1 AT 05785092 T AT05785092 T AT 05785092T AT 05785092 T AT05785092 T AT 05785092T AT E495439 T1 ATE495439 T1 AT E495439T1
Authority
AT
Austria
Prior art keywords
point source
cells
methods
testing apparatus
cell activity
Prior art date
Application number
AT05785092T
Other languages
English (en)
Inventor
Richard Goodwin
Original Assignee
Neuro Probe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neuro Probe Inc filed Critical Neuro Probe Inc
Application granted granted Critical
Publication of ATE495439T1 publication Critical patent/ATE495439T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
    • B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5029—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell motility
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
    • B01L2300/0874—Three dimensional network
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/08—Geometry, shape and general structure
    • B01L2300/0887—Laminated structure
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2400/00—Moving or stopping fluids
    • B01L2400/04—Moving fluids with specific forces or mechanical means
    • B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
    • B01L2400/0472—Diffusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Dispersion Chemistry (AREA)
  • Clinical Laboratory Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Fluid Mechanics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT05785092T 2004-08-12 2005-08-11 Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren ATE495439T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60078304P 2004-08-12 2004-08-12
PCT/US2005/028546 WO2006020766A2 (en) 2004-08-12 2005-08-11 Point source diffusion cell activity assay apparatuses and methods

Publications (1)

Publication Number Publication Date
ATE495439T1 true ATE495439T1 (de) 2011-01-15

Family

ID=35908137

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05785092T ATE495439T1 (de) 2004-08-12 2005-08-11 Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren

Country Status (8)

Country Link
US (3) US7547525B2 (de)
EP (1) EP1786921B1 (de)
JP (1) JP5191731B2 (de)
AT (1) ATE495439T1 (de)
AU (1) AU2005272814B2 (de)
CA (1) CA2576431C (de)
DE (1) DE602005025892D1 (de)
WO (1) WO2006020766A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE495439T1 (de) 2004-08-12 2011-01-15 Neuro Probe Inc Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren
US8082392B2 (en) * 2009-04-28 2011-12-20 Lsi Corporation Managing storage array operations that cause loss of access to mirrored data
JP5166360B2 (ja) * 2009-06-23 2013-03-21 株式会社島津製作所 マイクロ反応装置を用いた細胞運動評価方法
JP2012228183A (ja) * 2011-04-22 2012-11-22 Npo Keihanna Bunka Gakujutsu Kyokai 生物活性測定装置および最小生育阻止濃度推定方法
TWI640624B (zh) * 2014-08-29 2018-11-11 國立清華大學 細胞觀測裝置及使用其之細胞收集方法
CN107211286B (zh) * 2015-02-11 2021-08-24 IPCom两合公司 用于配置单频网络的方法和设备
US10384207B2 (en) 2015-07-21 2019-08-20 Neuro Probe Incorporated Assay apparatus and methods
CN108798628B (zh) * 2018-04-27 2021-06-15 成都理工大学 基于毛管力作用的气液分离计量装置
CN112970738B (zh) * 2019-12-02 2023-08-11 深圳拜尔洛克生物技术有限公司 一种利用水凝胶向生物材料进行溶液投送的方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5200152A (en) * 1988-03-28 1993-04-06 Cytonix Corporation Miniaturized biological assembly
US4912057A (en) 1989-06-13 1990-03-27 Cancer Diagnostics, Inc. Cell chamber for chemotaxis assay
US5763266A (en) 1989-06-15 1998-06-09 The Regents Of The University Of Michigan Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
US5210021A (en) 1991-03-20 1993-05-11 Neuro Probe, Inc. Multiple-site chemotactic test apparatus and method
US5284753A (en) 1991-03-20 1994-02-08 Neuro Probe, Inc. Multiple-site chemotactic test apparatus and method
US5302515A (en) 1992-08-20 1994-04-12 Neuro Probe, Inc. Chemotactic test apparatus and method
US5514555A (en) 1993-03-12 1996-05-07 Center For Blood Research, Inc. Assays and therapeutic methods based on lymphocyte chemoattractants
US5716849A (en) * 1994-06-08 1998-02-10 Novartis Finance Corporation Genes for the biosynthesis of soraphen
US5874301A (en) 1994-11-21 1999-02-23 National Jewish Center For Immunology And Respiratory Medicine Embryonic cell populations and methods to isolate such populations
US5601997A (en) 1995-02-03 1997-02-11 Tchao; Ruy Chemotaxis assay procedure
EP0727481B1 (de) 1995-02-16 2003-04-16 Forschungszentrum Jülich Gmbh Verfahren zur Kultivierung von Organfunktionszellen
US6329164B1 (en) 1999-03-18 2001-12-11 Neuro Probe, Incorporated Method for using a cell activity assay apparatus
US6287340B1 (en) 1999-05-14 2001-09-11 Trustees Of Tufts College Bioengineered anterior cruciate ligament
US20020009743A1 (en) 2000-05-17 2002-01-24 Carpenter Melissa K. Neural progenitor cell populations
WO2002042766A2 (en) * 2000-10-26 2002-05-30 University Of Connecticut A system and method for investigating the effect of chemical and other factors on cell movement
CA2411524C (en) 2000-12-08 2007-02-27 Flexcell International Corporation Method and apparatus to grow and mechanically condition cell cultures
CA2437084C (en) 2001-01-29 2010-12-21 Ivan N. Rich High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation
US7201873B2 (en) * 2001-04-16 2007-04-10 Tosoh Corporation Fine channel device, method for producing the fine channel device and use of the same
US7179643B2 (en) 2001-06-14 2007-02-20 Reliance Life Sciences Pvt. Ltd. Device and a process for expansion of haemopoeitic stem cells for therapeutic use
US20030044879A1 (en) * 2001-08-28 2003-03-06 Michael Beyer Method and device for forming a concentration gradient for chemotactic evaluation through use of laminar flow
WO2003062508A1 (en) 2002-01-18 2003-07-31 Neuro Probe Incorporated Crystal forming apparatus and method for using same
US7332029B2 (en) 2002-01-18 2008-02-19 Neuro Probe Incorporated Crystal forming apparatus and method for using same
US7232547B2 (en) 2002-03-22 2007-06-19 Marshfield Clinic Apparatus and method for testing and continuously reading low-volume samples
US7091035B2 (en) 2002-12-30 2006-08-15 The United States Of America As Represented By The Department Of Health And Human Services Cell culturing and storage systems, devices and methods
ATE495439T1 (de) 2004-08-12 2011-01-15 Neuro Probe Inc Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren

Also Published As

Publication number Publication date
EP1786921A2 (de) 2007-05-23
EP1786921A4 (de) 2007-12-05
US7547525B2 (en) 2009-06-16
CA2576431C (en) 2014-04-22
JP5191731B2 (ja) 2013-05-08
US8129175B2 (en) 2012-03-06
US20060035311A1 (en) 2006-02-16
DE602005025892D1 (de) 2011-02-24
HK1109427A1 (en) 2008-06-06
US8486655B2 (en) 2013-07-16
EP1786921B1 (de) 2011-01-12
AU2005272814B2 (en) 2010-12-23
JP2008509669A (ja) 2008-04-03
CA2576431A1 (en) 2006-02-23
WO2006020766A3 (en) 2006-05-18
US20090246860A1 (en) 2009-10-01
WO2006020766A2 (en) 2006-02-23
AU2005272814A1 (en) 2006-02-23
US20120122141A1 (en) 2012-05-17

Similar Documents

Publication Publication Date Title
MX2016002632A (es) Dispositivo y metodos para usar un dispositivo para la deteccion de hiperamoniemia.
WO2010027446A3 (en) Synaptic vesicle cycling assays and systems
WO2012074972A3 (en) Non-destructive testing methods for fuel cell interconnect manufacturing
JP2009509168A5 (de)
EP2336794A4 (de) Vorrichtung und verfahren zur erfassung des leckstroms einer batterie sowie batterieantriebsvorrichtung und batteriepack mit der vorrichtung
GB2427468B (en) Cell separation device and method for the detection of EpCAM positive cells
EP4360541A3 (de) Erfassung des lebensdauerendes eines kontinuierlichen analytsensors
ATE495439T1 (de) Punktquellendiffusionszellaktivitätstestvorrich unen und -verfahren
WO2009131948A8 (en) High-throughput cell-based cftr assay
DK1989544T3 (da) T-celle-testmetode
EP4411361A4 (de) Mikroanalysechip, elektrolytkonzentrationsmesssystem und elektrolytkonzentrationsmessverfahren
WO2006017751A3 (en) Methods for the detection of molecular interactions within cells
NZ594843A (en) Method or system using biomarkers for the monitoring of a treatment
EA201500377A1 (ru) Способ обнаружения анализируемого вещества и определение его концентрации с использованием намагничиваемых гранул
WO2004019465A3 (en) Ex-situ pem fuel cell testing: towards visualizing gas diffusion
ATE499598T1 (de) Markierungsfreier einzelzelltest
WO2008137910A3 (en) Matrix stabilization of aggregation-based assays
ATE475884T1 (de) Detektion von zirkulierenden endothelzellen
ATE549417T1 (de) Diagnoseverfahren für osteoarthritis
ATE489632T1 (de) Antigennachweis
GB201107669D0 (en) Electrochemical sensor
ATE528640T1 (de) Detektionssysteme und -verfahren für flüssigkeitsgekoppelte defekte
GB0409775D0 (en) Assay
TW200739778A (en) A test structure and method for detecting charge effects during semiconductor processing using a delayed inversion point technique
DE60327776D1 (de) Sonden zum nachweis von tumorzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties